Cargando…
MMP-9 Serum Levels in Schizophrenic Patients during Treatment Augmentation with Sarcosine (Results of the PULSAR Study)
Aim: Find changes in matrix metallopeptidase-9 (MMP-9) levels during augmentation of antipsychotic treatment with sarcosine and a relationship between schizophrenia symptoms severity and initial level of MMP-9. Method: Fifty-eight patients with diagnosis of schizophrenia with predominant negative sy...
Autores principales: | Strzelecki, Dominik, Kałużyńska, Olga, Szyburska, Justyna, Wysokiński, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964451/ https://www.ncbi.nlm.nih.gov/pubmed/27409603 http://dx.doi.org/10.3390/ijms17071075 |
Ejemplares similares
-
Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study
por: Strzelecki, Dominik, et al.
Publicado: (2015) -
Sarcosine May Induce EGF Production or Inhibit the Decline in EGF Concentrations in Patients with Chronic Schizophrenia (Results of the PULSAR Study)
por: Pawlak, Agnieszka, et al.
Publicado: (2023) -
Two grams of sarcosine in schizophrenia – is it too much? A potential role of glutamate-serotonin interaction
por: Strzelecki, Dominik, et al.
Publicado: (2014) -
Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex
por: Strzelecki, Dominik, et al.
Publicado: (2015) -
Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia
por: Strzelecki, Dominik, et al.
Publicado: (2015)